Assessment of Enzyme Inhibition: A Review with Examples from the Development of Monoamine Oxidase and Cholinesterase Inhibitory Drugs
The actions of many drugs involve enzyme inhibition. This is exemplified by the inhibitors of monoamine oxidases (MAO) and the cholinsterases (ChE) that have been used for several pharmacological purposes. This review describes key principles and approaches for the reliable determination of enzyme a...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-07-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/22/7/1192 |
id |
doaj-deb3d502895c473da70df84f8fef60cd |
---|---|
record_format |
Article |
spelling |
doaj-deb3d502895c473da70df84f8fef60cd2020-11-24T20:45:30ZengMDPI AGMolecules1420-30492017-07-01227119210.3390/molecules22071192molecules22071192Assessment of Enzyme Inhibition: A Review with Examples from the Development of Monoamine Oxidase and Cholinesterase Inhibitory DrugsRona R. Ramsay0Keith F. Tipton1Biomedical Sciences Research Complex, University of St Andrews, St Andrews KY16 8QP, UKSchool of Biochemistry and Immunology, Trinity College, Dublin 2, IrelandThe actions of many drugs involve enzyme inhibition. This is exemplified by the inhibitors of monoamine oxidases (MAO) and the cholinsterases (ChE) that have been used for several pharmacological purposes. This review describes key principles and approaches for the reliable determination of enzyme activities and inhibition as well as some of the methods that are in current use for such studies with these two enzymes. Their applicability and potential pitfalls arising from their inappropriate use are discussed. Since inhibitor potency is frequently assessed in terms of the quantity necessary to give 50% inhibition (the IC50 value), the relationships between this and the mode of inhibition is also considered, in terms of the misleading information that it may provide. Incorporation of more than one functionality into the same molecule to give a multi-target-directed ligands (MTDLs) requires careful assessment to ensure that the specific target effects are not significantly altered and that the kinetic behavior remains as favourable with the MTDL as it does with the individual components. Such factors will be considered in terms of recently developed MTDLs that combine MAO and ChE inhibitory functions.https://www.mdpi.com/1420-3049/22/7/1192Alzheimer’s diseasel-deprenyl (selegiline)donepezilgalantamineinhibitor constantenzyme inhibitionmultitarget-directed ligand (MTDL)rasagilinerivastigmine |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Rona R. Ramsay Keith F. Tipton |
spellingShingle |
Rona R. Ramsay Keith F. Tipton Assessment of Enzyme Inhibition: A Review with Examples from the Development of Monoamine Oxidase and Cholinesterase Inhibitory Drugs Molecules Alzheimer’s disease l-deprenyl (selegiline) donepezil galantamine inhibitor constant enzyme inhibition multitarget-directed ligand (MTDL) rasagiline rivastigmine |
author_facet |
Rona R. Ramsay Keith F. Tipton |
author_sort |
Rona R. Ramsay |
title |
Assessment of Enzyme Inhibition: A Review with Examples from the Development of Monoamine Oxidase and Cholinesterase Inhibitory Drugs |
title_short |
Assessment of Enzyme Inhibition: A Review with Examples from the Development of Monoamine Oxidase and Cholinesterase Inhibitory Drugs |
title_full |
Assessment of Enzyme Inhibition: A Review with Examples from the Development of Monoamine Oxidase and Cholinesterase Inhibitory Drugs |
title_fullStr |
Assessment of Enzyme Inhibition: A Review with Examples from the Development of Monoamine Oxidase and Cholinesterase Inhibitory Drugs |
title_full_unstemmed |
Assessment of Enzyme Inhibition: A Review with Examples from the Development of Monoamine Oxidase and Cholinesterase Inhibitory Drugs |
title_sort |
assessment of enzyme inhibition: a review with examples from the development of monoamine oxidase and cholinesterase inhibitory drugs |
publisher |
MDPI AG |
series |
Molecules |
issn |
1420-3049 |
publishDate |
2017-07-01 |
description |
The actions of many drugs involve enzyme inhibition. This is exemplified by the inhibitors of monoamine oxidases (MAO) and the cholinsterases (ChE) that have been used for several pharmacological purposes. This review describes key principles and approaches for the reliable determination of enzyme activities and inhibition as well as some of the methods that are in current use for such studies with these two enzymes. Their applicability and potential pitfalls arising from their inappropriate use are discussed. Since inhibitor potency is frequently assessed in terms of the quantity necessary to give 50% inhibition (the IC50 value), the relationships between this and the mode of inhibition is also considered, in terms of the misleading information that it may provide. Incorporation of more than one functionality into the same molecule to give a multi-target-directed ligands (MTDLs) requires careful assessment to ensure that the specific target effects are not significantly altered and that the kinetic behavior remains as favourable with the MTDL as it does with the individual components. Such factors will be considered in terms of recently developed MTDLs that combine MAO and ChE inhibitory functions. |
topic |
Alzheimer’s disease l-deprenyl (selegiline) donepezil galantamine inhibitor constant enzyme inhibition multitarget-directed ligand (MTDL) rasagiline rivastigmine |
url |
https://www.mdpi.com/1420-3049/22/7/1192 |
work_keys_str_mv |
AT ronarramsay assessmentofenzymeinhibitionareviewwithexamplesfromthedevelopmentofmonoamineoxidaseandcholinesteraseinhibitorydrugs AT keithftipton assessmentofenzymeinhibitionareviewwithexamplesfromthedevelopmentofmonoamineoxidaseandcholinesteraseinhibitorydrugs |
_version_ |
1716814574698627072 |